Gene-diet interaction on cancer risk in epidemiological studies

Journal of Preventive Medicine and Public Health

Volumn 42, Issue 6, 2009, Pages 360-370

  Lee, Sang Ah ^a  

^a Kangwon National University   (South Korea)

Author keywords

Carcinogen metabolizing gene dietary factors; Gene diet interaction; Onecarbon metabolism related gene; Oxidative stress related gene

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CARCINOGEN; FOLIC ACID; HETEROCYCLIC AMINE; HOMOCYSTEINE; METHIONINE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; VITAMIN B GROUP;

AMINO ACID BLOOD LEVEL; CANCER RISK; CARBON METABOLISM; CARCINOGENESIS; DIETARY INTAKE; DNA METHYLATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME SUBSTRATE; FRUIT; GENE DIET INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MEAT; MOLECULAR EPIDEMIOLOGY; OXIDATIVE STRESS; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VEGETABLE;

DIET; EPIDEMIOLOGIC STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; NUTRITIONAL STATUS; OXIDATIVE STRESS; PHENOTYPE; POLYMORPHISM, GENETIC; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS;

EID: 77953660521     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2009.42.6.360     Document Type: Review

References (101)

1. Beetstra S, Thomas P, Salisbury C, Turner J, Fenech M. Folic acid deficiency increases chromosomal instability, chromosome 21 aneuploidy and sensitivity to radiation-induced micronuclei. Mutat Res 2005; 578(1-2): 317-326.
2. Duthie SJ. Folic acid deficiency and cancer Mechanisms of DNA instability. Br Med Bull 1999; 55(3): 578-592.
3. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001; 475(1-2): 7-20.
4. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Jin F, et al. MTR and MTRR plymorphisrns, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(3): 586-588.
5. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 2004; 159(5): 423443. (Pubitemid 38280289)
6. Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, et al. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 2009; 18(4): 1101-1110.
7. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008; 29(2): 356-362. (Pubitemid 351359675)
8. Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: A population-based case-control study and meta-analyses. Int J Cancer 2007; 120(12): 2696-2703.(Pubitemid 46651293)
9. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 2007; 16(6): 1140-1147. (Pubitemid 46984950)
10. Xu X, Gammon MD, Wetmur JG, Rao M, Gaudet MM, Teitelbaum SL, et al. A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am J Clin Nutr 2007; 85(4): 1098-1102. (Pubitemid 46557927)
11. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005; 65(4): 1606-1614.
12. Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2004; 13(12): 2071-2077. (Pubitemid 40054300)
13. Wang J, Gajalakshmi V, Jiang J, Kuriki K, Suzuki S, Nagaya T, et al. Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer A case-control study in an Indian population. Int J Cancer 2006; 118(4): 991-997. (Pubitemid 43157676)
14. Murtaugh MA, Curtin K, Sweeney C, Wolff RK, Holubkov R, Caan BJ, et al. Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control 2007; 18(2): 153-163.
15. Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, et al. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev 2005; 29(2): 146-154. (Pubitemid 40514391)
16. Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, et al. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003; 12(10): 970-979. (Pubitemid 37310251)
17. Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE. The MTHFR C677T polymorphism and colorectal cancer: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005; 14(5): 1198-1203. (Pubitemid 40656467)
18. Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis 2007; 28(7): 1510-1519. (Pubitemid 47243540)
19. van den Donk M, Buijsse B, van den Berg SW, Ocke MC, Harryvan JL, Nagengast FM, et al. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: A Dutch case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14(6): 1562-1566.
20. 6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2008; 17(1): 171-182. (Pubitemid 351196288)
21. Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, et al. Colorectal adenomas and the C677T MTHFR polymorphism: Evidence for gene-environment interaction? Cancer Epidemiol Biomarken Prev 1999; 8(8): 659-668. (Pubitemid 30064533)
22. 2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 2005; 53(1): 42-50. (Pubitemid 43068552)
23. Boyapati SM, Bostick RM, McGlynn KA, Fina MF, Roufail WM, Geisinger KR, et al. Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States). Cancer Causes Control 2004; 15(5): 493-501.
24. Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C - >T polymorphism affect cancer risk: Intake recommendations. J Nutr 2003; 133(11 Suppl 1): 3748S-3753S.
25. Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: Effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000; 46(8 Pt 1): 1065-1071. (Pubitemid 30643306)
26. McNulty H, McKinley MC, Wilson B, McPartlin J, Strain JJ, Weir DG, et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: Implications for riboflavin requirements. Am J Clin Nutr 2002; 76(2): 436441. (Pubitemid 34804069)
27. Jacques PF, Kalmbach R, Bagley PJ, Russo GT, Rogers G, Wilson PW, et al. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr 2002; 132(2): 283-288. (Pubitemid 34135608)
28. Shi Q, Zhang Z, Neumann AS, Li G, Spitz MR, Wei Q. Case-control analysis of thymidylate synthase plymorphisms and risk of lung cancer. Carcinogenesis 2005; 26(3): 649-656. (Pubitemid 41214156)
29. Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, et al. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: A case-control analysis. Pharmacogenet Genomics 2005; 15(8): 547-555. (Pubitemid 41044240)
30. Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, et al. Sex differences in risk of lung cancer associated with methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev 2005; 14(6): 1477-1484. (Pubitemid 40807349)
31. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J 2003; 17(10): 1195-1214. (Pubitemid 36775767)
32. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999; 26(1-2): 202-226.
33. Li Y, Ambrosone CB, McCullough MJ, Ann J, Stevens VL, Thun MJ, et al. Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 2009; 30(5): 777-784.
34. He C, Tamimi RM, Hankinson SE, Hunter DJ, Han J. A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res Treat 2009; 113(3): 585-594.
35. Lee SA, Fowke JH, Lu W, Ye C, Zheng Y, Cai Q, et al. Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. Am J Clin Nutr 2008; 87(3): 753-760.
36. Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, et al. Associations between catalase phenotype and genotype: Modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev. 2006; 15(6): 1217-1222.
37. Slanger TE, Chang-Claude J, Wang-Gohrke S. Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population. Cancer Causes Control 2006; 17(8): 1025-1031. (Pubitemid 44290767)
38. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, et al. Vitamin D pathway gene plymorphisms, diet, and risk of postmenopausal breast cancer: A nested case-control study. Breast Cancer Res 2007; 9(1): R9. (Pubitemid 350215152)
39. Ann J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 2006; 27(9): 1876-1882.
40. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14(2): 336-342. (Pubitemid 40270094)
41. Shen J, Terry MB, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, et al. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005; 26(12): 2131-2137. (Pubitemid 41672201)
42. Gaudet MM, Gammon MD, Santella RM, Britton JA, Teitelbaum SL, Eng SM, et al. MnSOD Val-9Ala genotype, pro- and antioxidant environmental modifiers, and breast cancer among women on Long Island, New York. Cancer Causes Control 2005; 16(10): 1225-1234.
43. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162(10): 943-952. (Pubitemid 41619465)
44. Ann J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res 2004; 64(20): 7634-7639. (Pubitemid 39372111)
45. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999; 59(3): 602-606. (Pubitemid 29076057)
46. Ambrosone CB, Coles BF, Freudenheim JL, Shields PG. Glutathione-S- transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants. J Nutr 1999; 129(2S Suppl): 565S-568S.
47. Lancaster JR Jr, Xie K. Tumors face NO problems? Cancer Res 2006; 66(13): 6459-6462.
48. Arnhold J. Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc) 2004; 69(1): 4-9.
49. Gilbert DL, Colton CA. Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach. New York: Kluwer Academic/Plenum Publishers; 1999.
50. Egeberg R, Olsen A, Autrup H, Christensen J, Stripp C, Tetens I, et al. Meat consumption, N-acetyl transferase 1 and 2 polymorphism and risk of breast cancer in Danish postmenopausal women. Eur J Cancer Prev 2008; 17(1): 39-47. (Pubitemid 350307516)
51. Brandt B, Hermann S, Straif K, Tidow N, Buerger H, Chang-Claude J. Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene. Cancer Res 2004; 64(1): 7-12. (Pubitemid 38114073)
52. van der Hel OL, Peeters PH, Hein DW, Doll MA, Grobbee DE, Ocke M, et al. GSTM1 null genotype, red meat consumption and breast cancer risk (The Netherlands). Cancer Causes Control 2004; 15(3): 295-303. (Pubitemid 38988038)
53. Krajinovic M, Ghadirian P, Richer C, Sinnett H, Gandini S, Perret C, et al. Genetic susceptibility to breast cancer in French-Canadians: Role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer 2001; 92(2): 220-225. (Pubitemid 32225373)
54. Delfino RJ, Sinha R, Smith C, West J, White E, Lin HJ, et al. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis 2000; 21(4): 607-615. (Pubitemid 30214014)
55. Deitz AC, Zheng W, Leff MA, Gross M, Wen WQ, Doll MA, et al. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000; 9(9): 905-910. (Pubitemid 30743512)
56. Gertig DM, Hankinson SE, Hough H, Spiegelman D, Colditz GA, Willett WC, et al. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer 1999; 80(1): 13-17. (Pubitemid 28559768)
57. Ambrosone CB, Freudenheim JL, Sinha R, Graham S, Marshall JR, Vena JE, et al. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer 1998; 75(6): 825-830. (Pubitemid 28134105)
58. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene; A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996; 226(2): 561-565.
59. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ, et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005; 65(6): 2498-2504. (Pubitemid 40490163)
60. Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Wu K, Erdman JW Jr, et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 2008; 29(12): 2335-2340.
61. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey AB, Harper PA. Red meat intake, doneness, polymorphisms in genes that encode carcinogen- metabolizing enzymes, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17(11): 3098-3107.
62. Butler LM, Millikan RC, Sinha R, Keku TO, Winkel S, Harlan B, et al. Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat Res 2008; 638(1-2): 162-174.
63. Kury S, Buecher B, Robiou-du-Pont S, Scoul C, Sebille V, Colman H, et al. Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol Biomarkers Prev 2007; 16(7): 1460-1467. (Pubitemid 47076879)
64. Berndt SI, Platz EA, Fallin MD, Thuita LW, Hoffman SC, Helzlsouer KJ. Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(11): 2263-2269. (Pubitemid 44877054)
65. Murtaugh MA, Ma KN, Caan BJ, Sweeney C, Wolff R, Samowitz WS, et al. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2005; 14(5): 1224-1229. (Pubitemid 40656471)
66. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidermol Biomarken Prev 2005; 14(4): 863-870. (Pubitemid 40478549)
67. Tiemersma EW, Voskuil DW, Bunschoten A, Hogendoorn EA, Witteman BJ, Nagengast FM, et al. Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control 2004; 15(3): 225-236. (Pubitemid 38988031)
68. Sweeney C, Coles BF, Nowell S, Lang NP, Kadlubar FF. Novel markers of susceptibility to carcinogens in diet: Associations with colorectal cancer. Toxicology 2002; 181-182: 83-87. (Pubitemid 36015677)
69. Le Marchand L, Donlon T, Seifried A, Wilkens LR. Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11(10 Pt 1): 1019-1024.
70. Tiemersma EW, Kampman E, Bueno de Mesquita HB, Bunschoten A, van Schothorst EM, Kok FJ, et al. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: Results from a Dutch prospective study. Cancer Causes Control 2002; 13(4): 383-393. (Pubitemid 34553519)
71. Wright ME, Peters U, Gunter MJ, Moore SC, Lawson KA, Yeager M, et al. Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Cancer Res 2009; 69(4): 1429-1438.
72. Zhou XF, Cui J, DeStefano AL, Chazaro I, Farrer LA, Manolis AI, et al. Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers 2005; 21(1): 3-7. (Pubitemid 40387204)
73. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991; 349(6308): 431434. (Pubitemid 21926107)
74. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11(4): 409412. (Pubitemid 34408221)
75. Sorensen M, Raaschou-Nielsen O, Hansen RD, Tjonneland A, Overvad K, Vogel U. Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic Res 2006; 40(8): 885-891. (Pubitemid 44480499)
76. Hecht SS. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J Nutr 1999; 129(3): 768S-774S.
77. London SJ, Yuan JM, Chung FL, Gao YT, Coetzee GA, Ross RK, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: A prospective study of men in Shanghai, China. Lancet 2000; 356(9231): 724-729.
78. Lewis S, Brennan P, Nyberg F, Ahrens W, Constantinescu V, Mukeria A, et al. Re: Spitz, M. R., Duphorne, C. M., Detry, M. A., Pillow, P. C., Arnos, C. I., Lei, L., de Andrade, M., Gu, X., Hong, W. K., and Wu, X. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomark. Prev., 9: 1017-1020, 2000.
79. Cancer Epidemiol Biomarken Prev 2001; 10(10): 1105-1106.
80. Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, et al. Dietary isothiocyanates, glutathione S-rransferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 2001; 10(10): 1063-1067. (Pubitemid 32959153)
81. Wang LI, Giovannucci EL, Hunter D, Neuberg D, Su L, Christiani DC. Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control 2004; 15(10): 977-985.
82. Takezaki T, Gao CM, Wu JZ, Li ZY, Wang JD, Ding JH, et al. hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 2002; 99(4): 624-627.
83. Tsukino H, Hanaoka T, Otani T, Iwasaki M, Kobayashi M, Hara M, et al. hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci 2004; 95(12): 977-983. (Pubitemid 40089590)
84. Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, et al. Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 2005; 26(8): 1354-1359. (Pubitemid 41417877)
85. Hansen RD, Krath BN, Frederiksen K, Tjonneland A, Overvad K, Roswall N, et al. GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat Res 2009; 664(1-2): 13-19.
86. Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Jensen M, et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarken Prev 1994; 3(8): 675-682. (Pubitemid 24377961)
87. Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 1997; 37: 269-296. (Pubitemid 27238877)
88. Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, et al. Human acetyltransferase polymorphisms. Mutat Res 1997; 376(1-2): 61-70.
89. Snyderwine EG. Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer. Cancer 1994; 74(3 Suppl): 1070-1077.
90. Kampman E, Slattery ML, Bigler J, Leppert M, Samowitz W, Caan BJ, et al. Meat consumption, genetic susceptibility, and colon cancer risk: A United States multicenter case-control study. Cancer Epidemiol Biomarkers Prev 1999; 8(1): 15-24. (Pubitemid 29090865)
91. Welfare MR, Cooper J, Bassendine MF, Daly AK. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis 1997; 18(7): 1351-1354. (Pubitemid 28134708)
92. Le Marchand L, Hankin JH, Wilkens LR, Pierce LM, Franke A, Kolonel LN, et al. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10(12): 1259-1266. (Pubitemid 34027757)
93. Murtaugh MA, Sweeney C, Ma KN, Potter JD, Caan BJ, Wolff RK, et al. Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer 2006; 55(1): 3543. (Pubitemid 44477043)
94. Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola J Jr, Laginha FM, et al. Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. Cancer Sci 2009; 100(5): 927-933.
95. Hedelin M, Balter KA, Chang ET, Bellocco R, Klint A, Johansson JE, et al. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 2006; 66(14): 1512-1520. (Pubitemid 44467833)
96. Low YL, Taylor JI, Grace PB, Mulligan AA, Welch AA, Scollen S, et al. Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. Nutr Cancer 2006; 56(1): 31-39. (Pubitemid 46173412)
97. Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, et al. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidembl Biomarken Prev 2007; 16(5): 912-916.
98. Wong HL, Seow A, Arakawa K, Lee HP, Yu MC, Ingles SA. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 2003; 24(6): 1091-1095. (Pubitemid 36827261)
99. Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 2001; 12(7): 607-614. (Pubitemid 32758592)
100. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Int J Cancer 2008; 123(3): 586-593.
101. Dai Q, Shrubsole MJ, Ness RM, Schlund D, Cai Q, Smalley WE, et al. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr 2007; 86(3): 743-751. (Pubitemid 47435843)